摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Epinephrine ascorbate | 62265-31-0

中文名称
——
中文别名
——
英文名称
Epinephrine ascorbate
英文别名
(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
Epinephrine ascorbate化学式
CAS
62265-31-0
化学式
C15H21NO9
mdl
——
分子量
359.33
InChiKey
KOUXVSUXTJGEEM-GJZRPOMESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.06
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    180
  • 氢给体数:
    8
  • 氢受体数:
    10

文献信息

  • ASCORBATE-ISOQUERCETIN COMPOSITIONS
    申请人:MERCK PATENT GmbH
    公开号:EP1105121A1
    公开(公告)日:2001-06-13
  • US7041652B1
    申请人:——
    公开号:US7041652B1
    公开(公告)日:2006-05-09
  • [EN] PHARMACEUTICAL IMMUNOADJUVANT OR IMMUNOSTIMULATING COMPOSITIONS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES IMMUNOADJUVANTES OU IMMUNOSTIMULANTES
    申请人:LABORATOIRES DOLISOS
    公开号:WO1995005195A1
    公开(公告)日:1995-02-23
    (EN) The invention relates to the utilization of at least one of the following peptides: Lys-His-Gly (bursine), Lys-Gly-His, Gly-His-Lys, Gly-Lys-His, His-Lys-Gly, His-Gly-Lys, and particularly bursine, with a concentration not exceeding 10-8 approximately, particularly 10-10 or less for the preparation of an immunostimulating agent or an adjuvant for vaccination purposes, for humans or animals.(FR) L'invention concerne l'utilisation de l'un au moins des peptides suivants: Lys-His-Gly (bursine), Lys-Gly-His, Gly-His-Lys, Gly-Lys-His, His-Lys-Gly, His-Gly-Lys et notamment de la bursine, à une concentration égale ou inférieure à environ 10-8, notamment inférieure ou égale à 10-10, pour la préparation d'un immunostimulant ou d'un adjuvant de vaccination, pour l'homme ou pour l'animal.
  • [EN] ASCORBATE-ISOQUERCETIN COMPOSITIONS<br/>[FR] COMPOSITIONS D'ASCORBATE-ISOQUERCETINE
    申请人:MERCK PATENT GMBH
    公开号:WO2000012085A1
    公开(公告)日:2000-03-09
    The present invention relates to novel compositions containing ascorbic acid and one or more derivates of quercetin which orally administred conveys in vivo higher protection, longer maintenance of biological activity, higher concentration in tissues and higher biological efficiency to vitamin C in organs in human body. These compositions are useful as pharmaceutical compositions and as food supplements possessing preventive properties against damages of human organs, including skin, tissues and cells due to oxidative stress or damages.
查看更多